title: Components of the revised International Prognostic Scoring System and outcome after hematopoietic cell transplantation for myelodysplastic syndrome.
authors: Aaron T
authors: AT
authors: Gerds
authors: Ted A
authors: TA
authors: Gooley
authors: Wendy A
authors: WA
authors: Wilson
authors: H Joachim
authors: HJ
authors: Deeg
mesh_terms: D005069:Evaluation Studies as Topic; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods; D006801:Humans; D038622:Internationality; D015999:Multivariate Analysis; D009190:Myelodysplastic Syndromes / Q000175:diagnosis* / Q000401:mortality / Q000628:therapy*; D011379:Prognosis; D012107:Research Design; D012189:Retrospective Studies; D016019:Survival Analysis; D016896:Treatment Outcome
references: Blood. 2002 Aug 15;100(4):1201-7
references: 12149198
references: Bone Marrow Transplant. 2007 Oct;40(8):753-8
references: 17700600
references: Leukemia. 1998 Sep;12 Suppl 1:S25-9
references: 9777891
references: Blood. 2012 Sep 20;120(12):2454-65
references: 22740453
references: N Engl J Med. 2011 Jun 30;364(26):2496-506
references: 21714648
references: J Clin Oncol. 2012 Mar 10;30(8):820-9
references: 22331955
references: Blood. 1997 Mar 15;89(6):2079-88
references: 9058730
references: Blood. 2011 Dec 8;118(24):6239-46
references: 21998214
references: Blood. 2012 Aug 16;120(7):1398-408
references: 22767498